Novo Nordisk known as a pioneer biotechnology and bio pharmaceutical corporation developing new molecular cure for diabetic and diseases.
Novo Nordisk CEO, Lars Fruergaard Jørgensen by 2022 is facing an economical challenge under global economic recession. Denmark, Home of Novo Nordisk is under economical and political pressure of Russia's invasion of Ukraine.
It seems that Mr. Jorgensen with master science of Finance and Business can solve the problems but there are also lots of big challenge in front of this company.
China as one of the pioneer suppliers of pharmaceutical primary material is changing policy and facing multiple time COVID19 lock down. The thing that damage to the chain of supply .
It seems that during next 5 years Novo Nordisk will face big economical challenge by the way.
